Despite the rapidly evolving treatment landscape in advanced non-small-cell lung cancer
(NSCLC), developments in neoadjuvant and adjuvant treatments have been nascent by …

Context Stereotactic ablative radiotherapy (SABR) is an emerging treatment option for
primary renal cell carcinoma (RCC). Objective To systematically review the literature on …

Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …

Background Previous phase 2 trials of neoadjuvant anti-PD-1 or anti-PD-L1 monotherapy in
patients with early-stage non-small-cell lung cancer have reported major pathological …

Background The role of radiotherapy in metastatic renal cell carcinoma is controversial. We
prospectively tested the feasibility and efficacy of radiotherapy to defer systemic therapy for …

Background Ovarian cancer is a common malignancy in the female reproductive system with
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …

Neoadjuvant immunotherapy involves administering immune checkpoint inhibitors before
surgical resection in high-risk resectable disease. This strategy was shown to have a high …

Background and purpose We studied the benefits of using stereotactic MR-guided adaptive
radiation therapy (SMART) for delivery of SABR in peripherally located lung tumors …

Objectives: Identify the etiology of squamous cell lung cancer. Assess the appropriate
history, physical, and evaluation of squamous cell lung cancer. Evaluate the management …

Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …